67 related articles for article (PubMed ID: 32046983)
1. Alzheimer-Related Protein Suppresses Gliomas.
Cancer Discov; 2020 Mar; 10(3):332. PubMed ID: 32046983
[TBL] [Abstract][Full Text] [Related]
2. Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring.
Chaumeil MM; Radoul M; Najac C; Eriksson P; Viswanath P; Blough MD; Chesnelong C; Luchman HA; Cairncross JG; Ronen SM
Neuroimage Clin; 2016; 12():180-9. PubMed ID: 27437179
[TBL] [Abstract][Full Text] [Related]
3. The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas.
Mu L; Long Y; Yang C; Jin L; Tao H; Ge H; Chang YE; Karachi A; Kubilis PS; De Leon G; Qi J; Sayour EJ; Mitchell DA; Lin Z; Huang J
Front Mol Neurosci; 2018; 11():82. PubMed ID: 29643764
[No Abstract] [Full Text] [Related]
4. Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas.
Cai J; Zhu P; Zhang C; Li Q; Wang Z; Li G; Wang G; Yang P; Li J; Han B; Jiang C; Sun Y; Jiang T
Oncotarget; 2016 Mar; 7(13):16384-95. PubMed ID: 26918938
[TBL] [Abstract][Full Text] [Related]
5. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Chen R; Cohen AL; Colman H
Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas.
Hersh DS; Peng S; Dancy JG; Galisteo R; Eschbacher JM; Castellani RJ; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
J Neurooncol; 2018 Jun; 138(2):241-250. PubMed ID: 29453678
[TBL] [Abstract][Full Text] [Related]
7. IDH1 status is significantly different between high-grade thalamic and superficial gliomas.
Zuo M; Li M; Chen N; Yu T; Kong B; Liang R; Wang X; Mao Q; Liu Y
Cancer Biomark; 2017 Aug; 20(2):183-189. PubMed ID: 28869450
[TBL] [Abstract][Full Text] [Related]
8. ZEB1 expression is increased in IDH1-mutant lower-grade gliomas.
Nesvick CL; Zhang C; Edwards NA; Montgomery BK; Lee M; Yang C; Wang H; Zhu D; Heiss JD; Merrill MJ; Ray-Chaudhury A; Zhuang Z
J Neurooncol; 2016 Oct; 130(1):111-122. PubMed ID: 27568035
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.
Reich TR; Switzeny OJ; Renovanz M; Sommer C; Kaina B; Christmann M; Tomicic MT
Oncotarget; 2017 Feb; 8(9):15071-15084. PubMed ID: 28122345
[TBL] [Abstract][Full Text] [Related]
10. IDH1 Mutation in Gliomas in Mosul City - Iraq.
Saeed MS
Open Access Maced J Med Sci; 2015 Jun; 3(2):250-5. PubMed ID: 27275230
[TBL] [Abstract][Full Text] [Related]
11. IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomas.
Liubinas SV; D'Abaco GM; Moffat BM; Gonzales M; Feleppa F; Nowell CJ; Gorelik A; Drummond KJ; O'Brien TJ; Kaye AH; Morokoff AP
Epilepsia; 2014 Sep; 55(9):1438-43. PubMed ID: 24903073
[TBL] [Abstract][Full Text] [Related]
12. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.
Salloum R; McConechy MK; Mikael LG; Fuller C; Drissi R; DeWire M; Nikbakht H; De Jay N; Yang X; Boue D; Chow LML; Finlay JL; Gayden T; Karamchandani J; Hummel TR; Olshefski R; Osorio DS; Stevenson C; Kleinman CL; Majewski J; Fouladi M; Jabado N
Acta Neuropathol Commun; 2017 Oct; 5(1):78. PubMed ID: 29084603
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic
Beyer SJ; Bell EH; McElroy JP; Fleming JL; Cui T; Becker A; Bassett E; Johnson B; Gulati P; Popp I; Staszewski O; Prinz M; Grosu AL; Haque SJ; Chakravarti A
Oncotarget; 2018 Dec; 9(98):37097-37111. PubMed ID: 30647847
[TBL] [Abstract][Full Text] [Related]
14. Brain T1ρ mapping for grading and IDH1 gene mutation detection of gliomas: a preliminary study.
Cao M; Ding W; Han X; Suo S; Sun Y; Wang Y; Qu J; Zhang X; Zhou Y
J Neurooncol; 2019 Jan; 141(1):245-252. PubMed ID: 30414094
[TBL] [Abstract][Full Text] [Related]
15. Novel Functions of the Neurodegenerative-Related Gene Tau in Cancer.
Gargini R; Segura-Collar B; Sánchez-Gómez P
Front Aging Neurosci; 2019; 11():231. PubMed ID: 31551755
[TBL] [Abstract][Full Text] [Related]
16. Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression.
Pirozzi CJ; Carpenter AB; Waitkus MS; Wang CY; Zhu H; Hansen LJ; Chen LH; Greer PK; Feng J; Wang Y; Bock CB; Fan P; Spasojevic I; McLendon RE; Bigner DD; He Y; Yan H
Mol Cancer Res; 2017 May; 15(5):507-520. PubMed ID: 28148827
[No Abstract] [Full Text] [Related]
17. Whole-Tumor Histogram and Texture Analyses of DTI for Evaluation of
Park YW; Han K; Ahn SS; Choi YS; Chang JH; Kim SH; Kang SG; Kim EH; Lee SK
AJNR Am J Neuroradiol; 2018 Apr; 39(4):693-698. PubMed ID: 29519794
[TBL] [Abstract][Full Text] [Related]
18. Anatomical localization of isocitrate dehydrogenase 1 mutation: a voxel-based radiographic study of 146 low-grade gliomas.
Wang Y; Zhang T; Li S; Fan X; Ma J; Wang L; Jiang T
Eur J Neurol; 2015 Feb; 22(2):348-54. PubMed ID: 25318355
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular characterization of IDH1-mutated diffuse low grade gliomas reveals tumor heterogeneity and absence of EGFR/PDGFRα activation.
Azar S; Leventoux N; Ripoll C; Rigau V; Gozé C; Lorcy F; Bauchet L; Duffau H; Guichet PO; Rothhut B; Hugnot JP
Glia; 2018 Feb; 66(2):239-255. PubMed ID: 29027701
[TBL] [Abstract][Full Text] [Related]
20. An immuno-wall microdevice exhibits rapid and sensitive detection of IDH1-R132H mutation specific to grade II and III gliomas.
Yamamichi A; Kasama T; Ohka F; Suzuki H; Kato A; Motomura K; Hirano M; Ranjit M; Chalise L; Kurimoto M; Kondo G; Aoki K; Kaji N; Tokeshi M; Matsubara T; Senga T; Kaneko MK; Suzuki H; Hara M; Wakabayashi T; Baba Y; Kato Y; Natsume A
Sci Technol Adv Mater; 2016; 17(1):618-625. PubMed ID: 27877908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]